Akso Health Group 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Linda Wang

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.1yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	2.6yrs

최근 관리 업데이트

Recent updates

CEO

Linda Wang (37 yo)

3.1yrs

테뉴어

Ms. Yilin Wang also known as Linda, serves as Chief Executive Officer and Chairwoman of the Board at Akso Health Group (formerly known as Xiaobai Maimai Inc.) since October 18, 2021. She served as Co-Chief...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yilin Wang	CEO & Chairwoman of the Board	3.1yrs	데이터 없음	데이터 없음
Stephen P. Brown	Independent Non-Executive Director	2.6yrs	데이터 없음	데이터 없음
Wenjuan Liu	Director	3.3yrs	데이터 없음	데이터 없음
Gerald T. Neal	Independent Non-Executive Director	2.4yrs	데이터 없음	데이터 없음
Zhe Liu	Independent Non-Executive Director	2.1yrs	데이터 없음	데이터 없음

2.6yrs

평균 재임 기간

39yo

평균 연령

경험이 풍부한 이사회: AHG 의 이사회는 경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Akso Health Group 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Akso Health Group, Annual General Meeting, Apr 30, 2024

Akso Health Group, Annual General Meeting, Jun 19, 2023

Less than half of directors are independent

Less than half of directors are independent

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Now 33% undervalued after recent price drop

Estimating The Intrinsic Value Of Akso Health Group (NASDAQ:AHG)

New major risk - Share price stability

Now 21% undervalued

Now 24% undervalued

Full year 2024 earnings released: US$0.19 loss per share (vs US$0.58 loss in FY 2023)

New minor risk - Financial data availability

Akso Health Group, Annual General Meeting, Apr 30, 2024

AHG Announces Plan to Acquire Online Clinic

Akso Health Group announced that it has received $13.974055 million in funding

Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Full year 2023 earnings released: US$0.58 loss per share (vs US$0.85 loss in FY 2022)

New minor risk - Shareholder dilution

Akso Health Group, Annual General Meeting, Jun 19, 2023

First half 2023 earnings released: EPS: US$0.035 (vs US$0.53 loss in 1H 2022)

Full year 2022 earnings released: US$0.85 loss per share (vs US$1.94 loss in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

Akso Health receives non-compliance notice from Nasdaq

Akso Health Group announced delayed 20-F filing

High number of new and inexperienced directors

High number of new and inexperienced directors

Akso Health Group Announces Board Changes

Akso Health Group Announces Board and Committee Changes

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Akso Health Group(NasdaqGM:AHG) dropped from NASDAQ Composite Index

Xiaobai Maimai Eyes Cancer Treatment As E-Commerce Pivot Sputters

New 90-day high: US$2.78

New 90-day high: US$2.67

Hexindai reports 1H results

Hexindai Inc. to Report First Half, 2021 Results on Dec 21, 2020

Hexindai Inc., Annual General Meeting, Dec 16, 2020

Hexindai Inc. Launches Elite Influencers Program on Xiaobai Maimai

Hexindai Inc. announced delayed 20-F filing

CEO

테뉴어

이사회 구성원

평균 재임 기간

평균 연령